Tech Company Financing Transactions

CaloSyn Pharma Funding Round

On 6/30/2009, CaloSyn Pharma received $400 thousand in funding from BVM Capital and MB Venture Partners.

Transaction Overview

Company Name
Announced On
6/30/2009
Transaction Type
Venture Equity
Amount
$400,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
26 Firebrick Rd.
Sharon, MA 02067
USA
Website
Email Address
Not Recorded
Overview
The company is developing intra-articular therapeutics for osteoarthritis.
Profile
CaloSyn Pharma LinkedIn Company Profile
Social Media
CaloSyn Pharma Company Twitter Account
Company News
CaloSyn Pharma News
Facebook
CaloSyn Pharma on Facebook
YouTube
CaloSyn Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Martin Becker
  Martin Becker LinkedIn Profile  Martin Becker Twitter Account  Martin Becker News  Martin Becker on Facebook
Chief Executive Officer
Stephen Snowdy
  Stephen Snowdy LinkedIn Profile  Stephen Snowdy Twitter Account  Stephen Snowdy News  Stephen Snowdy on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2009: Body Evolution venture capital transaction
Next: 6/30/2009: AirPlay Network venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary